Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1467335 in Non-proliferative Diabetic Retinopathy
NCT03238963Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2017
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of PXS-4728A, sponsored by Boehringer Ingelheim. Started Sep 2017; status: completed.
02
Drugs
PXS-4728A
Beyond the preview
Go deeper on NCT03238963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238963.